acquisto levitra acquisto viagra buy accupril buy accutane aceon aciphex advair diskus aleve buy allegra amaryl buy amoxil amoxil antabuse buy augmentin buy caverta buy celebrex cheap cialis buy cipro buy clomid buy diflucan buy glucophage buy inderal buy kamagra buy lamisil buy lasix buy levitra buy lexapro buy nolvadex buy phenergan buy premarin buy propecia buy prozac buy silagra buy synthroid buy tadalis buy ultram buy viagra online buy zithromax cheap levitra cheap viagra comprare cialis generic cialis generic viagra generic viagra kaufen cialis kaufen propecia kaufen rimonabant kaufen viagra viagra online buy viagra buy cialis buy levitra buy zithromax buy cheap viagra buy viagra buy generic viagra buy cialis buy cialis online buy levitra buy propecia buy kamagra buy acomplia buy kamagra buy accutane buy amoxil buy augmentin buy celebrex buy cialis soft tabs buy cipro buy clomid buy diflucan buy effexor buy glucophage buy lasix buy lexapro buy lipitor buy cytotec buy nexium buy nolvadex buy prednisone buy prilosec buy prozac buy rimonabant buy soma buy synthroid buy tramadol buy ultram buy wellbutrin buy xenical buy zithromax buy zyban buy zyvox buy zyrtec buy zyprexa buy zyloprim buy zovirax buy zometa buy zoloft buy zofran buy zocor buy zimulti buy zetia buy zestril buy zestoretic buy zerit buy zelnorm buy zebeta buy zantac buy zanaflex buy zaditor buy xeloda buy wellbutrin sr buy vytorin buy vpxl buy voltaren buy vitaliq buy viramune buy vibramycin buy vermox buy ventolin buy vasotec buy vasodilan buy vantin buy vanadyl buy valtrex buy uroxatrol buy urispas buy ultracet buy tulasi buy triphala buy trimox buy trileptal buy tricor buy tribulus buy triamterene buy trental buy trazodone buy trandate buy tramaden buy torsemide buy toradol buy toprol xl buy topamax buy tofranil buy tetracycline buy terramycin buy tenormin buy accutane buy acomplia buy amoxil buy antabuse buy bactrim buy cafergot buy carisoprodol buy cialis buy cialis professional buy cialis soft tabs buy cialis super active buy cipro buy clomid buy cytotec buy depakote buy dilantin buy doxycycline buy female viagra buy flagyl er buy fluoxetine buy furosemide buy inderal buy lasix buy levaquin buy levitra buy levitra professional buy lexapro buy lipitor buy nexium buy nolvadex buy paxil buy penis growth oil buy penis growth patch buy penis growth pills buy phentrimine buy prednisone buy propecia buy prozac buy retin-a buy rimonabant buy robaxin buy singulair buy soma buy stromectol buy sumycin buy tagamet buy tenormin buy tetracycline buy torsemide buy tramadol buy trazodone buy triamterene buy ultracet buy ultram buy viagra buy viagra professional buy viagra soft tabs buy viagra super active buy voltaren buy vpxl buy zelnorm buy zithromax buy zoloft buy zyprexa buy zyban buy xenical

Dual Diagnosis and Dual Diagnosis Treatment Today

Research and study of the brain is beginning to unlock the mystery of dual disorders. For years the psychiatric field has either ignored dual diagnosis (a dual diagnosis was impossible prior to DSM III due to exclusionary criteria and DSM I & II forbidding multiple diagnoses), or treated personality as the underlying cause of substance abuse.

The drug addiction treatment field believed abstinence from mood altering drugs would cause the psychiatric symptoms to disappear. Research has not found a single underlying personality variable to account for substance abuse disorders, nor has drug addiction research found the remission of psychiatric disorders with abstinence. Both theories have highlighted the need for research/dual diagnosis treatment specifically aimed at the complexities of dual diagnosis. Some research suggests deficits in neurological functioning as a precursor for dual diagnosis in some people ( Chappel etal. 35). Self-medication of Axis I disorders, and symptomatic relief of Axis II diagnoses has also been cited as the cause of dual disorders (Kessler et al., 1996; Walker, 1992). Others highlight psychosocial factors such as poverty and parental absence (Rahav et al., 1995), physical and sexual abuse and neglect (Henderson et al., 1994; Alexander et al., 1994), and cultural norms of the inner city (Rhav et al., 1995), as playing pivotal roles in the development of dual diagnoses. In fact some (Jones & Katz, 1992), suggest that the lack of concern for issues related to dual diagnosis is directly related to many being poor minorities. While the two diseases do exacerbate each other there are numerous causal interactions that must be addressed to lead to more specific diagnosis and effective dual diagnosis treatment strategies.

The term dual diagnosed began to surface in the 1980’s. The development of DSM-III with its multiaxial system and allowing of multiple diagnoses began the identification of dually occurring psychiatric and substance use disorders. The former Commissioner of Mental Health in Tennessee, Evelyn Robertson states, over the past 20 years the deinstitutionalization movement has indirectly created a generation of chronic patients with a high prevalence of alcohol and drug abuse (200). With the development of Jellinek’s “disease model” of alcoholism (Jellinek, 1960), and the founding of Alcoholics Anonymous (a self-help program that assists individuals who seek sobriety through mutual support of other recovering individuals) substance abuse treatment began to flourish. This posed a problem for many physicians, and especially psychiatrists, who viewed alcoholism as the result of an underlying personality disturbance (Ridgely, Goldman, and Willenbring 125), or a disease to be treated by the drug addiction treatment field.

The primary goal of a drug treatment program in the recovery model is abstinence from mood altering substances. This conflicts with the psychiatric model that stresses emotional stability and commonly involves the use of medication. The ambiguous concept of the recovery model emphasizing “powerlessness” while the psychiatric model emphasizes “empowerment” is just an example of the philosophical differences (Sheeham 109). In the 1993 article Sheehan states, “The recovery model stresses addiction as the primary driving force behind the addicts’ problems. Simply stated, this model asserts that abstinence resolves the “psychiatric symptoms”. In contrast, the psychiatric or psychodynamic model identifies psychiatric symptoms or some deeper psychiatric conflict as the motivating force behind chemical abuse and dependence.”(109)

This population is growing at an alarming rate and the latest epidemiological data (Kessler et al., 1996) suggests a 79% rate of dual diagnosis in those meeting criteria for any single psychiatric disorder. These researchers found that during the year previous to data collection only 1/3 of these people sought dual diagnosis treatment. In a 1997 Tennessean article “Double Trouble” Quigly reports 25,000 Tennessean’s suffer from dual disorders. Dixon and Osher report the staggering number of people with this illness is growing at such a pace it is overloading our public health system (3). Treatment for the dual diagnosed may depend on who the treatment professional(s)/provider(s) is/are and their theoretical orientation. Howland states, “As a result, conflicts may arise about the responsibility for the direction of treatment, leaving the patient confused or having to chose one over the other” (1135). Patients are often left feeling unsure if anyone can help since they often get conflicting stories from treatment providers. In short, the responsibility for integrating dual diagnosis treatment falls on the least capable individual, the consumer.

Recommendations for overcoming these problems include unification of these disparate approaches into an integrated system which could promote cross-training for the professionals/providers and the managed care system. Howland states, ” Ideally, funding and programming for mental health and substance abuse should be brought together into one system, rather than categorically distributed between separate systems” (1135). Drug treatment program providers have historically been unwilling to allow this to happen due to being over protective of their turf and being afraid of further reductions in funding. Two united systems could promote education, training and planning in both areas, allowing the providers to gain expertise in both domains. Comprehensive psychiatric and substance abuse evaluations should be performed no matter where the patient presents for treatment. Preferably, a drug treatment program would provide specialized services for the dual diagnosed client with both drug treatment program professionals working together simultaneously with both problems, instead of with the predominant issue (Howland 1135).

Lakeview Health Systems is an example of an integrated treatment model for the dual diagnosed. The treatment team, in the dual diagnosis treatment program, includes a psychiatrist, psychologist, licensed clinical social worker and addiction counselors. For more information on dual diagnosis research or dual diagnosis treatment go to either
www.dual-diagnosis-treatment-center.com or
www.recoveryconnection.org.

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

You must be logged in to post a comment.


FireStats icon Powered by FireStats